AstraZeneca eyes up transition to eco-friendly inhaler propellant
Results from AstraZeneca’s completed clinical studies will be shared with regulatory authorities by the end of this year.
Environmental Sustainability
Q2 2024 update: environmental sustainability related hiring actvity in the pharma industry
Scientists push for ‘greener’ drugs in published study
Q4 2023 update: environmental sustainability related M&A activity in the pharmaceutical industry
COP28 podcast: max 1.5°C temperature rise limit now ‘not possible’
COP28 podcast: max 1.5°C temperature rise limit now ‘not possible’
Why COP28 was the first COP to truly align with climate science
How COP28 raised the profile of ‘super pollutants’ like black carbon
